On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...